What to expect as FDA advisory panel debates Pfizer COVID booster shots
The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest data submitted by Pfizer and discuss whether a booster dose is safe enough for widespread use and whether it's necessary and effective…